A novel series of di-fluorinated propanedione derivatives synergistically augment paclitaxel mediated caspase 3 activation in ovarian cancer cells. [electronic resource]
Producer: 20150629Description: 701-9 p. digitalISSN:- 1998-4138
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Caspase 3 -- metabolism
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Resistance, Neoplasm
- Drug Synergism
- Enzyme Activation -- drug effects
- Female
- Humans
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- pharmacology
- Poly(ADP-ribose) Polymerases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.